These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30315646)

  • 41. [Correlation analysis of cement leakage with volume ratio of intravertebral bone cement to vertebral body and vertebral body wall incompetence in percutaneous vertebroplasty for osteoporotic vertebral compression fractures].
    Liang D; Ye L; Jiang X; Huang W; Yao Z; Tang Y; Zhang S; Jin D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Nov; 28(11):1358-63. PubMed ID: 25639050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between body composition and age, menopause and its effects on bone mineral density at segmental regions in Central Southern Chinese postmenopausal elderly women with and without osteoporosis.
    Liu S; Li J; Sheng Z; Wu X; Liao E
    Arch Gerontol Geriatr; 2011; 53(2):e192-7. PubMed ID: 20880598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
    Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of adiponectin and sex steroid hormones on bone mineral density and bone formation markers in postmenopausal women with subclinical hyperthyroidism.
    Ahn KH; Lee SH; Park HT; Kim T; Hur JY; Kim YT; Kim SH
    J Obstet Gynaecol Res; 2010 Apr; 36(2):370-6. PubMed ID: 20492390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evaluation of hormonal and psychological parameters that affect bone mineral density in postmenopausal women.
    Seven A; Yuksel B; Kabil Kucur S; Yavuz G; Polat M; Unlu BS; Keskin N
    Eur Rev Med Pharmacol Sci; 2016; 20(1):20-5. PubMed ID: 26813449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
    Palomba S; Orio F; Manguso F; Falbo A; Russo T; Tolino A; Tauchmanovà L; Colao A; Doldo P; Mastrantonio P; Zullo F
    Osteoporos Int; 2005 Sep; 16(9):1141-9. PubMed ID: 15928801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution of bone mineral density after percutaneous kyphoplasty in fresh osteoporotic vertebral body fractures and adjacent vertebrae along with sagittal spine alignment.
    Korovessis P; Zacharatos S; Repantis T; Michael A; Karachalios D
    J Spinal Disord Tech; 2008 Jun; 21(4):293-8. PubMed ID: 18525491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
    Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
    Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study.
    Zanchetta JR; Bogado CE; Cisari C; Aslanidis S; Greisen H; Fox J; Lems W
    Curr Med Res Opin; 2010 Nov; 26(11):2627-33. PubMed ID: 20923256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women.
    Huang AJ; Ettinger B; Vittinghoff E; Ensrud KE; Johnson KC; Cummings SR
    J Bone Miner Res; 2007 Nov; 22(11):1791-7. PubMed ID: 17620054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site.
    Kim BJ; Rhee Y; Kim CH; Baek KH; Min YK; Kim DY; Ahn SH; Kim H; Lee SH; Lee SY; Kang MI; Koh JM
    Bone; 2015 Dec; 81():435-441. PubMed ID: 26297442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Zhao Y; Xue R; Shi N; Xue Y; Zong Y; Lin W; Pei B; Sun C; Fan R; Jiang Y
    Osteoporos Int; 2016 Nov; 27(11):3309-3317. PubMed ID: 27245056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical Predictors of Low Bone Mineral Density and Fracture Susceptibility in Maltese Postmenopausal Women.
    Formosa MM; Xuereb-Anastasi A
    Calcif Tissue Int; 2016 Jan; 98(1):28-41. PubMed ID: 26400554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.